Renalytix AI (GB:RENX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Renalytix’s Executive Chairman, Julian Baines, has increased his stake in the company by purchasing nearly 24,000 shares, showcasing confidence in the firm’s future. This strategic move aligns with Renalytix’s ongoing efforts to revolutionize kidney health diagnostics through AI-driven solutions. The transaction took place on the London Stock Exchange at a price of £0.0725 per share.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.
